Navigation Links
Early Detection Of Primary Liver Cancer Would Save Millions Of Lives

Researchers at the University of Birmingham had developed a new technology that will help in the early diagnosis of liver cancer among people who are at a high risk. It is a blood test, which measures the protein levels // combined with the computer analysis, which can detect typical; changes seen in the early liver cancer patients.

This discovery would save millions of lives because live cancer is one of the most prevalent diseases. If it were diagnosed in the early stage then it would be easy to treat the patient. The findings of the research were published in the British Journal of Cancer.

Hepatocellular carcinoma or liver cancer is the sixth most common cancer in the world and it is widespread in East Asia. Usually people with cirrhosis of the liver are more prone to develop liver cancer and hence highly sensitive tests are required to detect the disease and prevent it among the patients suffering from liver cirrhosis.

Professor Philip Johnson said that through this research they were able to distinguish people who had early liver cancer from those who without the disease. This method is very accurate and sensitive than any of the present techniques such as the existing liver cancer blood test.

But further studies have to be performed so that the test can be performed on many people.

Apart from cirrhosis of the liver various disease that cause damage to the liver like the hepatitis B and C viruses, causing Hepatitis greatly increase the risk of hepatocellular carcinoma.

Vaccinations against the hepatitis B virus are now administered to children to protect them against the disease, but there are millions of people who are already infected with the disease. In case of hepatitis C, there is no effective vaccine and the incidence of liver cancer still remains high in the global scenario.

At present high-risk groups can be screened with the help of ultrasound scans and test for the presence of a single protein in the blood called alpha-fetoprotein. Though it is a good indicator of advanced stages of the liver cancer, but it is a poor indicator of early stage liver cancer.


'"/>




Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early therapy aids eyesight
11. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... More than 20,000 pairs of ... Congo (DRC) thanks to an ambitious venture that conjoined the passions of an NBA ... support of the Liberty community. These shoes will save lives from the rampant infections ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the launch ... lifestyles and highlighting the importance of proactive eye and ear health. The campaign ... latest innovations in hearing aid technology. , In this issue, the National ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... 2017 , ... Radabaugh & Associates, a family managed agency ... West Virginia, is embarking on a cooperative charity effort with the Chestnut Mountain ... Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school for young men offering ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Brian Gifford Agency, an ... is campaigning in support of Campagna Academy in a charity drive to provide for ... Boys’ Town of Indiana,” Campagna Academy is a nonprofit organization that has offered critical ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... AccuGenomics, Inc., a diagnostic company based in ... the company has provided an AccuKit to the HIV ... Chapel Hill and to Qura Therapeutics for evaluation in ... HIV reservoir and viral expression in human CD4+ T ... Center is a joint initiative between the University of ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: